Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
human necessities (99) 99
hygiene (99) 99
medical or veterinary science (99) 99
preparations for medical, dental, or toilet purposes (99) 99
chemistry (44) 44
metallurgy (44) 44
specific therapeutic activity of chemical compounds ormedicinal preparations (40) 40
peptides (28) 28
organic chemistry (27) 27
index medicus (20) 20
beer (17) 17
biochemistry (17) 17
compositions or test papers therefor (17) 17
condition-responsive control in microbiological orenzymological processes (17) 17
enzymology (17) 17
investigating or analysing materials by determining theirchemical or physical properties (17) 17
measuring (17) 17
measuring or testing processes involving enzymes, nucleicacids or microorganisms (17) 17
microbiology (17) 17
mutation or genetic engineering (17) 17
physics (17) 17
processes of preparing such compositions (17) 17
spirits (17) 17
testing (17) 17
vinegar (17) 17
wine (17) 17
male (16) 16
humans (14) 14
urology & nephrology (14) 14
female (11) 11
adult (8) 8
middle aged (8) 8
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (7) 7
aged (6) 6
animals (6) 6
double-blind method (6) 6
hyperparathyroidism, secondary - drug therapy (6) 6
nephrology (6) 6
parathyroid hormone - blood (6) 6
secondary hyperparathyroidism (6) 6
calcium - blood (5) 5
child (5) 5
hyperparathyroidism, secondary - etiology (5) 5
rats (5) 5
treatment outcome (5) 5
vitamin d (5) 5
children (4) 4
ergocalciferols - administration & dosage (4) 4
hemodialysis-patients (4) 4
kidney failure, chronic - complications (4) 4
parathyroid-hormone (4) 4
paricalcitol (4) 4
phosphorus - blood (4) 4
rats, sprague-dawley (4) 4
renal dialysis (4) 4
administration, oral (3) 3
adolescent (3) 3
aged, 80 and over (3) 3
agriculture (3) 3
animal husbandry (3) 3
biocides, e.g. as disinfectants, as pesticides, as herbicides (3) 3
bone-disease (3) 3
brush-border membrane (3) 3
calcitriol (3) 3
child, preschool (3) 3
chronic kidney disease (3) 3
citrate (3) 3
depletion (3) 3
end-stage renal disease (3) 3
fishing (3) 3
forestry (3) 3
hunting (3) 3
kidney - metabolism (3) 3
kidney failure, chronic - therapy (3) 3
original report: patient-oriented, translational research (3) 3
pest repellants or attractants (3) 3
plant growth regulators (3) 3
potassium (3) 3
preservation of bodies of humans or animals or plants or partsthereof (3) 3
renal insufficiency, chronic - complications (3) 3
research (3) 3
stage renal-disease (3) 3
transport (3) 3
trapping (3) 3
urolithiasis (3) 3
1 alpha-hydroxyvitamin-d3 (2) 2
abridged index medicus (2) 2
acidosis (2) 2
acute kidney injury - complications (2) 2
adaptation (2) 2
astrophysics (2) 2
atp citrate lyase (2) 2
blood pressure (2) 2
calcifediol (2) 2
calcium (2) 2
cells (2) 2
chronic disease (2) 2
citrate-synthase - metabolism (2) 2
citric acid - urine (2) 2
clinical trials (2) 2
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (121) 121
French (27) 27
Chinese (14) 14
German (13) 13
Korean (8) 8
Portuguese (4) 4
Spanish (3) 3
Japanese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Mo1245 - Effect of Creon Therapy on Exocrine Pancreatic Insufficiency Symptoms and Coefficient of Fat Absorption Associated with Chronic Pancreatitis
by Barkin, Jodie A and Barkin, Jamie S and Hall, Jerry A and Liao, Qiming and Melnick, Joel Z
Gastroenterology, ISSN 0016-5085, 05/2018, Volume 154, Issue 6, pp. S-719 - S-719
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Antiproteinuric effect of oral paricalcitol in chronic kidney disease
by Agarwal, Rajiv and Acharya, Muralidhar and Tian, J.I.N and Hippensteel, Richard L and Melnick, Joel Z and Qiu, Ping and Williams, Laura and Batlle, Daniel
Kidney International, ISSN 0085-2538, 12/2005, Volume 68, Issue 6, pp. 2823 - 2828
Antiproteinuric effect of oral paricalcitol in chronic kidney disease. Proteinuria is a marker of cardiovascular and renal disease in patients with chronic... 
chronic kidney disease | paricalcitol | proteinuria | vitamin D | Chronic kidney disease | Vitamin D | Paricalcitol | Proteinuria | CELLS | PREVENTION | RISK | NEPHROPATHY | BLOOD-PRESSURE | VITAMIN-D ANALOG | HYPERTROPHY | UROLOGY & NEPHROLOGY | HEMODIALYSIS | 1,25-DIHYDROXYVITAMIN D-3 | Hyperparathyroidism, Secondary - metabolism | Hyperparathyroidism, Secondary - drug therapy | Administration, Oral | Humans | Middle Aged | Male | Treatment Outcome | Renal Insufficiency, Chronic - complications | Renal Insufficiency, Chronic - drug therapy | Proteinuria - drug therapy | Parathyroid Hormone - metabolism | Ergocalciferols - administration & dosage | Female | Aged | Hyperparathyroidism, Secondary - etiology | Proteinuria - complications | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text 117: Open Label, Placebo-Controlled, Randomized, Single Dose Escalation and Repeat Dose Study of Intravenous CTA018 in Healthy Volunteers
by Karjalainen, Jukka and Warren, Jeffery and Melnick, Joel Z and Willmer, Jonathan
American Journal of Kidney Diseases, ISSN 0272-6386, 2008, Volume 51, Issue 4, pp. B57 - B57
Nephrology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease
by Sprague, Stuart M and Crawford, Paul W and Melnick, Joel Z and Strugnell, Stephen A and Ali, Shaukat and Mangoo-Karim, Roberto and Lee, Sungchun and Petkovich, P. Martin and Bishop, Charles W
American Journal of Nephrology, ISSN 0250-8095, 10/2016, Volume 44, Issue 4, pp. 316 - 325
Background/Aims: Vitamin D insufficiency and secondary hyperparathyroidism (SHPT) are associated with increased morbidity and mortality in chronic kidney... 
Original Report: Patient-Oriented, Translational Research | Chronic kidney disease | Calcifediol (25-hydroxyvitamin D3) | Vitamin D | Vitamin D insufficiency | Parathyroid hormone | Secondary hyperparathyroidism | VITAMIN-D INSUFFICIENCY | HEMODIALYSIS-PATIENTS | D DEFICIENCY | UROLOGY & NEPHROLOGY | Calcifediol (25-hydroxyvitamin D-3) | RENAL-DISEASE | PREVALENCE | Humans | Middle Aged | Vitamin D Deficiency - drug therapy | Male | Parathyroid Hormone - blood | Renal Insufficiency, Chronic - complications | Calcium - blood | Calcifediol - adverse effects | Vitamin D Deficiency - blood | Hyperparathyroidism - blood | Hyperparathyroidism - drug therapy | Female | Vitamin D Deficiency - etiology | Hyperparathyroidism - etiology | Glomerular Filtration Rate | Double-Blind Method | Calcifediol - therapeutic use | Calcium - urine | Vitamins - therapeutic use | Creatinine - urine | Renal Insufficiency, Chronic - physiopathology | Vitamin D - blood | Vitamins - adverse effects | Fibroblast Growth Factors - blood | Phosphorus - blood | Delayed-Action Preparations - therapeutic use | Vitamin D - analogs & derivatives | Aged | 24,25-Dihydroxyvitamin D 3 - blood | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Modified-Release Calcifediol Effectively Controls Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Chronic Kidney Disease
by Sprague, Stuart M and Silva, Arnold L and Al-Saghir, Fahd and Damle, Radhika and Tabash, Samir P and Petkovich, Martin and Messner, Eric J and White, Jay A and Melnick, Joel Z and Bishop, Charles W
American Journal of Nephrology, ISSN 0250-8095, 02/2015, Volume 40, Issue 6, pp. 535 - 545
Background/Aims: Vitamin D insufficiency drives secondary hyperparathyroidism (SHPT) and is associated with increased cardiovascular mortality in patients with... 
Original Report: Patient-Oriented, Translational Research | Parathyroid hormone (PTH) | Vitamin D | Calcifediol (25-hydroxyvitamin D | Secondary hyperparathyroidism (SHPT) | Vitamin D insufficiency | Calcitriol (1,25-dihydroxyvitamin D | Chronic kidney disease (CKD) | ERGOCALCIFEROL TREATMENT | SERUM PARATHYROID-HORMONE | 25-HYDROXYVITAMIN D | D DEFICIENCY | Calcifediol (25-hydroxyvitamin D-3) | RANDOMIZED CONTROLLED-TRIAL | ALL-CAUSE MORTALITY | INTESTINAL-ABSORPTION | GLOMERULAR-FILTRATION-RATE | UROLOGY & NEPHROLOGY | HYPOVITAMINOSIS D | Calcitriol (1,25-dihydroxyvitamin D-3) | CHOLECALCIFEROL SUPPLEMENTATION | Calcifediol - administration & dosage | Calcifediol - blood | Double-Blind Method | Hyperparathyroidism, Secondary - drug therapy | Humans | Middle Aged | Vitamin D Deficiency - drug therapy | Male | Parathyroid Hormone - blood | Renal Insufficiency, Chronic - complications | Vitamin D - blood | Renal Insufficiency, Chronic - blood | Hyperparathyroidism, Secondary - blood | Vitamin D Deficiency - blood | Adult | Female | Vitamin D - analogs & derivatives | Aged | Vitamins - blood | Hyperparathyroidism, Secondary - etiology | Vitamin D Deficiency - etiology | Delayed-Action Preparations | Vitamins - administration & dosage | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
by Heerspink, Hiddo J L and Parving, Hans-Henrik and Andress, Dennis L and Bakris, George and Correa-Rotter, Ricardo and Hou, Fan-Fan and Hou, Fanfan and Kitzman, Dalane W and Kohan, Donald and Makino, Shinya and Makino, Hirofumi and McMurray, John J V and Melnick, Joel Z and Miller, Michael G and Miller, Alan and Miller, Steven and Pergola, Pablo E and Pergola, Pablo and Perkovic, Vlado and Tobe, Sheldon and Yi, Joo Hark and Yi, Tingting and Wigderson, Melissa and de Zeeuw, Dick and Elbert, Alicia and Vallejos, Augusto and Alvarisqueta, Andres and Maffei, Laura and Juncos, Luis and de Arteaga, Javier and Greloni, Gustavo and Farias, Eduardo and Zucchini, Alfredo and Vogel, Daniel and Cusumano, Ana and Santos, Juan and Fraenkel, Margaret and Gallagher, Martin and Davis, Tim and Acharya, Shamasunder and Cooke, Duncan and Suranyi, Michael and Roger, Simon and Toussaint, Nigel and Pollock, Carol and Chan, Doris and Stranks, Stephen and MacIsaac, Richard and Endre, Zoltan and Schmidt, Alice and Schmidt, Rebecca and Prager, Rudolf and Mayer, Gert and Warling, Xavier and Jadoul, Michel and Hougardy, Jean and Vercammen, Chris and Van Vlem, Bruno and Gillard, Pieter and Costa e Forti, Adriana and Borges, Joao Lindolfo and Santos Canani, Luis and Eliaschewitz, Freddy and Leite, Silmara and Fraige Filho, Fadlo and Paschoalin, Raphael and Moura Neto, Jose Andrade and Deboni, Luciane and de Lourdes Noronha, Irene and Cercato, Cintia and Prompt, Carlos Alberto and Zanella, Maria and Rassi, Nelson and D'Avila, Domingos and Milagres, Rosangela and Felicio, Joao and Pecoits Filho, Roberto and Riella, Miguel Carlos and Salles, Joao and Keitel, Elizete and Draibe, Sergio and Amodeo, Celso and Youmbissi, Joseph and Roy, Louise and Cournoyer, Serge and Jolly, Shivinder and Pichette, Vincent and Nesrallah, Gihad and Bajaj, Harpreet Singh and Khandwala, Hasnain and Aronson, Ronnie and Goluch, Richard and Tam, Paul and Rabbat, Christian and Bailey, Gordon and Chow, Stephen and Castillo, Alvaro and Danin Vargas, Alfredo and Gonzalez, Fernando and Munoz, Rodrigo and ... and SONAR Comm Investigators and SONAR Committees and Investigators
The Lancet, ISSN 0140-6736, 05/2019, Volume 393, Issue 10184, pp. 1937 - 1947
Short-term treatment for people with type 2 diabetes using a low dose of the selective endothelin A receptor antagonist atrasentan reduces albuminuria without... 
MEDICINE, GENERAL & INTERNAL | INHIBITION | ENDOTHELIN | ALBUMINURIA | NEPHROPATHY | Humans | Middle Aged | Male | Diabetic Nephropathies - blood | Serum Albumin, Human - urine | Young Adult | Aged, 80 and over | Adult | Female | Diabetic Nephropathies - prevention & control | Endothelin A Receptor Antagonists - therapeutic use | Diabetic Nephropathies - urine | Glomerular Filtration Rate | Double-Blind Method | Endothelin A Receptor Antagonists - administration & dosage | Administration, Oral | Treatment Outcome | Creatinine - urine | Renal Insufficiency, Chronic - blood | Renal Insufficiency, Chronic - prevention & control | Atrasentan - therapeutic use | Creatinine - blood | Aged | Atrasentan - administration & dosage | Diabetes Mellitus, Type 2 - drug therapy | Renal Insufficiency, Chronic - urine | Short term | Enrichment | End-stage renal disease | Renal function | Endothelin | Heart attacks | Peptides | Clinical trials | Cardiovascular disease | Transplantation | Retention | Randomization | Renin | Motivation | Hemoglobin | Blood pressure | Safety | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Heart failure | Urine | Creatinine | Enzymes | Kidneys | Epidermal growth factor receptors | Anemia | Diabetes mellitus | Health risks | Patients | Disease control | Glomerular filtration rate | Sodium | Angiotensin | Renal failure | Dialysis | Kidney diseases | Diabetes | Surface area | Potassium | Kidney transplantation | Long-term effects | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text PARICALCITOL (A SELECTIVE VITAMIN D RECEPTOR ACTIVATOR) THERAPY FOR ICU-RELATED HYPOCALCEMIA IS ASSOCIATED WITH REDUCED INFECTIONS.: 287
by Douglas, Ivor S and Kaufman, David C and Amdahl, Michael J and Orzel, Stacey A and Williams, Laura A and Melnick, Joel Z
Critical Care Medicine, ISSN 0090-3493, 12/2006, Volume 34, Issue 12 Abstract supplement, pp. A78 - A78
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Oral Paricalcitol for the Treatment of Secondary Hyperparathyroidism in Patients on Hemodialysis or Peritoneal Dialysis
by Ross, Edward A and Tian, Jin and Abboud, Hanna and Hippensteel, Richard and Melnick, Joel Z and Pradhan, Rajendra S and Williams, Laura A and Hamm, L. Lee and Sprague, Stuart M
American Journal of Nephrology, ISSN 0250-8095, 11/2007, Volume 28, Issue 1, pp. 97 - 106
Background/Aims: Secondary hyperparathyroidism is a common complication of chronic kidney disease, resulting from inactivation of vitamin D receptor signaling... 
Original Report: Patient-Oriented, Translational Research | Chronic renal failure | Chronic renal insufficiency | Secondary hyperparathyroidism | Paricalcitol | SURVIVAL | PHOSPHORUS | paricalcitol | secondary hyperparathyroidism | chronic renal failure | VITAMIN-D ANALOGS | CALCIUM | RENAL-FAILURE | D-2 | UROLOGY & NEPHROLOGY | chronic renal insufficiency | CALCITRIOL | Hyperparathyroidism, Secondary - drug therapy | Administration, Oral | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Parathyroid Hormone - blood | Receptors, Calcitriol - metabolism | Kidney Failure, Chronic - therapy | Calcium - blood | Hyperparathyroidism, Secondary - blood | Ergocalciferols - adverse effects | Peritoneal Dialysis | Phosphorus - blood | Kidney Failure, Chronic - complications | Aged, 80 and over | Placebos | Adult | Ergocalciferols - administration & dosage | Female | Aged | Hyperparathyroidism, Secondary - etiology | Renal Dialysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings
by Dobrez, Deborah G and Mathes, Angelo and Amdahl, Michael and Marx, Steven E and Melnick, Joel Z and Sprague, Stuart M
Nephrology Dialysis Transplantation, ISSN 0931-0509, 05/2004, Volume 19, Issue 5, pp. 1174 - 1181
Background. Abnormalities of serum calcium, phosphorous and intact parathyroid hormone (PTH) are associated with morbidity and mortality in haemodialysis... 
Costs | Vitamin D | Hospitalizations | Haemodialysis | Multivariate | Hyperparathyroidism | Outcomes | costs | RISK-FACTORS | MANAGEMENT | vitamin D | haemodialysis | multivariate | SECONDARY HYPERPARATHYROIDISM | hyperparathyroidism | FAILURE | TRANSPLANTATION | CALCIPHYLAXIS | DIALYSIS PATIENTS | outcomes | HEMODIALYSIS-PATIENTS | UROLOGY & NEPHROLOGY | PARATHYROID-HORMONE | hospitalizations | STAGE RENAL-DISEASE | Hyperparathyroidism, Secondary - drug therapy | Risk Assessment | Humans | Kidney Failure, Chronic - complications | Medical Records | Hospitalization - statistics & numerical data | Ergocalciferols - therapeutic use | Treatment Outcome | Retrospective Studies | Calcitriol - therapeutic use | Hyperparathyroidism, Secondary - etiology | Renal Dialysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Intravenous Paricalcitol for Treatment of Secondary Hyperparathyroidism in Children on Hemodialysis
by Greenbaum, Larry A., MD, PhD and Benador, Nadine, MD and Goldstein, Stuart L., MD and Paredes, Ana, MD and Melnick, Joel Z., MD and Mattingly, Susan, BSN and Amdahl, Michael, MS and Williams, Laura A., MD, MPH and Salusky, Isidro B., MD
American Journal of Kidney Diseases, ISSN 0272-6386, 2007, Volume 49, Issue 6, pp. 814 - 823
Background Secondary hyperparathyroidism is a common complication in children receiving hemodialysis. Active vitamin D is an effective therapy, but its use is... 
Nephrology | hemodialysis | secondary hyperparathyroidism | end-stage renal disease | children | Paricalcitol | LONG-TERM | BONE-DISEASE | paricalcitol | 1 ALPHA-HYDROXYVITAMIN-D3 | PEDIATRIC-PATIENTS | UROLOGY & NEPHROLOGY | PARATHYROID-HORMONE | MINERAL METABOLISM | CALCIUM LEVELS | PTH SECRETION | CALCITRIOL THERAPY | STAGE RENAL-DISEASE | Hyperparathyroidism - etiology | Double-Blind Method | Humans | Bone Density Conservation Agents - therapeutic use | Child, Preschool | Ergocalciferols - therapeutic use | Male | Bone Density Conservation Agents - administration & dosage | Parathyroid Hormone - blood | Kidney Failure, Chronic - therapy | Calcium - blood | Kidney Failure, Chronic - blood | Phosphorus - blood | Adolescent | Kidney Failure, Chronic - complications | Hyperparathyroidism - blood | Hyperparathyroidism - drug therapy | Adult | Ergocalciferols - administration & dosage | Female | Infusions, Intravenous | Child | Renal Dialysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Contents Vol. 40, 2014
American Journal of Nephrology, ISSN 0250-8095, 02/2015, Volume 40, Issue 6, pp. I - VI
  No abstract available 
Further Section
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis
by Greenbaum, Larry A and Grenda, Ryszard and Qiu, Ping and Restaino, Irene and Wojtak, Amy and Paredes, Ana and Benador, Nadine and Melnick, Joel Z and Williams, Laura A and Salusky, Isidro B
Pediatric Nephrology, ISSN 0931-041X, 5/2005, Volume 20, Issue 5, pp. 622 - 630
This double-blind, placebo-controlled study evaluated the safety and efficacy of intravenous (IV) calcitriol (Calcijex) for treatment of secondary... 
Phosphorus | Renal osteodystrophy | Calcium | End stage renal disease | Secondary hyperparathyroidism | PARICALCITOL | BONE-DISEASE | secondary hyperparathyroidism | calcium | renal osteodystrophy | 1 ALPHA-HYDROXYVITAMIN-D3 | end stage renal disease | THERAPY | UROLOGY & NEPHROLOGY | PARATHYROID-HORMONE | MINERAL METABOLISM | CALCIFICATION | PEDIATRICS | PTH SECRETION | STAGE RENAL-DISEASE | phosphorus | Injections, Intravenous | Hyperparathyroidism, Secondary - drug therapy | Calcium Compounds | Humans | Calcitriol - adverse effects | Child, Preschool | Male | Parathyroid Hormone - blood | Chronic Kidney Disease-Mineral and Bone Disorder - drug therapy | Kidney Failure, Chronic - therapy | Calcitriol - administration & dosage | Calcium - blood | Calcium Channel Agonists - administration & dosage | Acetates - administration & dosage | Adolescent | Kidney Failure, Chronic - complications | Phosphates - blood | Female | Calcium Carbonate - administration & dosage | Calcium Channel Agonists - adverse effects | Chronic Kidney Disease-Mineral and Bone Disorder - etiology | Hyperparathyroidism, Secondary - etiology | Child | Renal Dialysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text A Comparison of Dosing Regimens of Paricalcitol Capsule for the Treatment of Secondary Hyperparathyroidism in CKD Stages 3 and 4
by Abboud, Hanna and Coyne, Daniel and Smolenski, Olgierd and Anger, Michael and Lunde, Norman and Qiu, Ping and Hippensteel, Rich and Pradhan, Rajendra S and Palaparthy, Rameshraja V and Kavanaugh, Anne and Melnick, Joel Z and Williams, Laura A and Batlle, Daniel
American Journal of Nephrology, ISSN 0250-8095, 04/2006, Volume 26, Issue 1, pp. 105 - 114
Background: Intermittent dosing of calcitriol for secondary hyperparathyroidism (SHPT) has been associated with greater parathyroid hormone (PTH) reduction... 
Original Report: Laboratory Investigation | Hypercalcemia | Once-daily dosing, paricalcitol | Vitamin D | Intermittent dosing, paricalcitol | Hyperphosphatemia | Pulse dosing, paricalcitol | Vitamin D receptor activator | BONE-DISEASE | vitamin D | INSUFFICIENCY | INTERMITTENT | OSTEODYSTROPHY | vitamin D receptor activator | intermittent dosing, paricalcitol | hypercalcemia | hyperphosphatemia | 1,25-DIHYDROXYVITAMIN-D3 | HEMODIALYSIS-PATIENTS | UROLOGY & NEPHROLOGY | PARATHYROID-HORMONE | pulse dosing, paricalcitol | CHRONIC KIDNEY-DISEASE | once-daily dosing, paricalcitol | CHRONIC-RENAL-FAILURE | CALCITRIOL | Prospective Studies | Double-Blind Method | Drug Administration Schedule | Hyperparathyroidism, Secondary - drug therapy | Humans | Middle Aged | Male | Parathyroid Hormone - blood | Vitamins - pharmacokinetics | Calcium - blood | Capsules | Phosphorus - blood | Ergocalciferols - pharmacokinetics | Aged, 80 and over | Adult | Ergocalciferols - administration & dosage | Female | Aged | Kidney Diseases - complications | Chronic Disease | Vitamins - administration & dosage | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Transient Renal Tubular Acidosis During Development Impairs Growth in Female Rats 1794
by Chang, Hsin-Yi and Akrami, Jason and Melnick, Joel Z
Pediatric Research, ISSN 0031-3998, 04/1998, Volume 43, pp. 306 - 306
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights